During her tenure as CEO of Medis Medical Imaging Systems, Dr. Barley has led the company to market leadership through new product development, as well as secured a strategic collaboration with GE Healthcare. An experienced leader with a broad range of executive positions in the medtech sector, Dr. Barley’s decades in the industry include roles in product management, marketing, clinical science, and R&D.
“Maya Barley has a wealth of experience in the development and management of medical enterprises benefiting humanity,” says David Hardwick, Chairman and Co-Founder of Norlase. “Dr. Barley will enhance the capabilities of our Board, particularly in strategic planning for our future. We look forward to working with her.”
Oliver Hvidt, Norlase CEO and President, stated, “With her deep expertise in technology, marketing, and leadership within the medical device industry, Maya will be a significant asset to Norlase as we continue to innovate and expand globally.”
“I am delighted to be joining the Board of Norlase, a company with a truly inspirational vision and the team and technology to realize it,” says Dr. Barley of her appointment. “I look forward to working with Norlase as they make the next step in their exciting journey.”
Dr. Barley’s appointment to the Norlase board is another landmark in the company’s growth as it continues to introduce its products into new markets globally . The company closed its biggest investment round yet in 2023, with $11 million USD in funding following the regulatory clearance of its third product, the ECHO Pattern Laser. Dr. Barley joins an expanding team of experts from across the medical device industry, who seek to advance what is possible for efficient, convenient ophthalmic laser technologies.
Prior to her tenure with Medis Medical, Dr. Barley served as Global Product Director at LumiraDx, where she oversaw critical product management and development projects. Her storied track record in the industry also includes a role as Innovation & Strategic Marketing Director at Keeler, where she reversed a two-decade decline in product output and spearheaded the development of AI-led retinal imaging products. She has held multiple senior roles at Phillips, including Director of Clinical Technologies, where she drove significant clinical research partnerships and developed integrated solution roadmaps across various diagnostic applications. She holds a PhD in Biomedical and Electrical Engineering from Harvard University and Massachusetts Institute of Technology (MIT).
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF®, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION®, the first fully integrated green laser and LIO; and ECHO®, the world’s first ultra-portable pattern scanning laser. Learn more at norlase.com.
During her tenure as CEO of Medis Medical Imaging Systems, Dr. Barley has led the company to market leadership through new product development, as well as secured a strategic collaboration with GE Healthcare. An experienced leader with a broad range of executive positions in the medtech sector, Dr. Barley’s decades in the industry include roles in product management, marketing, clinical science, and R&D.
“Maya Barley has a wealth of experience in the development and management of medical enterprises benefiting humanity,” says David Hardwick, Chairman and Co-Founder of Norlase. “Dr. Barley will enhance the capabilities of our Board, particularly in strategic planning for our future. We look forward to working with her.”
Oliver Hvidt, Norlase CEO and President, stated, “With her deep expertise in technology, marketing, and leadership within the medical device industry, Maya will be a significant asset to Norlase as we continue to innovate and expand globally.”
“I am delighted to be joining the Board of Norlase, a company with a truly inspirational vision and the team and technology to realize it,” says Dr. Barley of her appointment. “I look forward to working with Norlase as they make the next step in their exciting journey.”
Dr. Barley’s appointment to the Norlase board is another landmark in the company’s growth as it continues to introduce its products into new markets globally . The company closed its biggest investment round yet in 2023, with $11 million USD in funding following the regulatory clearance of its third product, the ECHO Pattern Laser. Dr. Barley joins an expanding team of experts from across the medical device industry, who seek to advance what is possible for efficient, convenient ophthalmic laser technologies.
Prior to her tenure with Medis Medical, Dr. Barley served as Global Product Director at LumiraDx, where she oversaw critical product management and development projects. Her storied track record in the industry also includes a role as Innovation & Strategic Marketing Director at Keeler, where she reversed a two-decade decline in product output and spearheaded the development of AI-led retinal imaging products. She has held multiple senior roles at Phillips, including Director of Clinical Technologies, where she drove significant clinical research partnerships and developed integrated solution roadmaps across various diagnostic applications. She holds a PhD in Biomedical and Electrical Engineering from Harvard University and Massachusetts Institute of Technology (MIT).
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF®, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION®, the first fully integrated green laser and LIO; and ECHO®, the world’s first ultra-portable pattern scanning laser. Learn more at norlase.com.
DIDN’T FIND WHAT YOU’RE LOOKING FOR?
Let us know how we can help!
DIDN’T FIND WHAT YOU
WERE LOOKING FOR?
Let us know how we can help!
